Why won't my weight move no matter what I do? Willpower was never the whole variable. Six measurable reasons account for most stubborn weight. The most common is fasting insulin that has climbed for years while glucose looked fine. A thyroid can sit at the top of its range and drift. Hormones shift through perimenopause or with low testosterone. Chronic inflammation, sleep that never restores and medications that quietly promote weight gain complete the list. All six live on blood work. A panel that reads them together is the honest first step. That is why the Biomarker Audit exists inside the flat $299 membership.

Key takeaways
  • Six measurable reasons account for most stubborn weight and all six live on blood work.
  • Fasting insulin rises years before glucose moves and is the most common hidden finding.
  • Thyroid position and trend, midlife hormones and inflammation all shift the same system.
  • The Biomarker Audit reads all of them together every 90 days inside the flat $299 fee.
  • Medication, including branded GLP-1 therapy where indicated, is billed by the pharmacy at pharmacy cost with zero markup.

The six reasons, measured one by one

One, insulin resistance. Fasting insulin rises early, sometimes a decade before HbA1c moves and elevated insulin is a storage signal. The person whose weight will not move despite eating well and moving often most often shows this line. It responds to treatment in months and it is invisible on a glucose-only screen.

Two, the thyroid line. A TSH at the top of the range that has been drifting upward for two years is a different patient from a TSH that has held there for ten and the portal flag looks identical for both. Position and trend matter and free T3 conversion is the piece the standard screen never reads.

Three, midlife hormones. Perimenopause and low testosterone change body composition and the story is system-wide rather than estrogen alone. Thyroid, insulin and inflammation move together in midlife, which is why the panel is read as one picture.

Four, inflammation. Hs-CRP is the audit's inflammation line and chronic inflammation changes how the body partitions energy. It is also the marker nobody checks when the answer is always eat less and move more.

Five, sleep. Fragmented sleep raises cortisol, increases appetite and mimics hypothyroidism. The screening questions are simple and the pattern is measurable on the panel.

Six, medications. Some antidepressants, steroids and insulin itself promote weight gain. A clinician reading the medication list alongside the panel is the only way to see it.

Why eat less and move more failed you

That advice is not wrong and it is incomplete. It treats the symptom while ignoring the six measurable reasons the symptom exists and it is delivered by a system that gets eight minutes and orders a glucose-only screen. The patients we meet are not arguing that calories do not matter. They are arguing that nobody ever looked for a cause.

The trial data on GLP-1 medication makes the physiological point plainly. In STEP-1, participants on semaglutide 2.4 mg lost about 15 percent of body weight over 68 weeks while following a lifestyle program they were not required to succeed at. Individual results vary. The medication works where willpower did not, because it changes the physiology that willpower was fighting.

Clinical note

A body that resists weight loss has a reason and the reason is usually on blood work rather than in character.

What the panel reads and how the protocol follows

The Biomarker Audit reads fasting insulin, HbA1c, ApoB, Lp(a), hs-CRP, the full lipid panel, the comprehensive metabolic panel, the CBC and TSH with reflex to free T4, with hormone panels added where the story calls for them. The clinician reads the panel against your history and builds the protocol on it.

When insulin resistance is the finding, the protocol addresses it directly. When the thyroid line is the finding, the thyroid gets the attention. When a GLP-1 fits, it is branded and FDA-approved, Wegovy, Zepbound, Ozempic, Mounjaro, Wegovy Tablets or Foundayo, never compounded, prescribed to the pharmacy you choose.

GoodLife Health. Medicine that builds on itself, $299 a month: 90-day labs, your clinician, branded GLP-1s, one platform. See if you qualify.GoodLife Health. $299 a month. Everything talks to everything: quarterly labs read by your clinician, branded GLP-1s prescribed from them, every result and dose tracked on one platform. See if you qualify.

What the $299 membership buys around this question

The structure is one flat fee for the doctor and zero markup on the medicine. The fee is $299 a month, month to month after a two-month start and it covers the clinical relationship, four Biomarker Audits a year, messaging with the care team and video visits. At sign-up a single $598 charge covers the first two months together. It is held when you apply and charged only once a clinician accepts you into care. If the clinician cannot accept you, the hold is released and you are never charged. Once accepted, the first two months are charged and non-refundable. From month three you can cancel anytime.

Medication is the second charge and it is always separate. Any prescription is written to the pharmacy you choose and billed by that pharmacy at its own price. GoodLife Health sets nothing, sees nothing and takes nothing on medication. There is no molecule upcharge and no dose upcharge, ever. The fee never rises with the dose, so the titration carries no profit motive on our side.

The first 90 days, if you join

It is worth describing what actually happens after the eligibility check, because the objection underneath the weight question is usually about being sold something rather than treated. You complete the eligibility check, a clinician reviews it and accepts you into care or not and the $598 first charge covers the first two months together. The first Biomarker Audit is scheduled within days. The draw takes ten minutes. Around day nine to thirteen you sit with the clinician and walk the whole panel, marker by marker and the protocol comes out of that conversation rather than from a template.

From there the rhythm is quarterly. Each audit measures whether the protocol is working, the clinician adjusts on the evidence and nothing about the fee changes in the process. If a branded GLP-1 fits the picture, it is prescribed to the pharmacy you choose and the pharmacy bills you at its own price while our fee stays flat. If the finding is insulin resistance alone, the protocol addresses it without a prescription, because the point is the least medicine that gets the most result.

What this structure deliberately does not do is decide the dose based on what it earns. The fee is $299 whether you need the lowest effective dose or the highest approved one, because there is no markup on the medicine and no revenue event in titration. That is the alignment the category lacks and it is the reason a person whose weight has been stuck for years can trust the plan that comes out of these visits.

The objection about paying for a membership when you already have a doctor

This one deserves a direct answer, because it is the most common hesitation behind the weight question. The membership does not replace every clinician in your life and it is not insurance. It replaces the primary-care relationship for the cardiometabolic questions, the weight, the insulin, the lipids, the blood pressure and the hormones that conventional primary care gets eight minutes for. Your dermatologist, your orthopedist and your insurance policy all stay exactly where they are.

What you are paying $299 a month for is the version of the primary-care relationship that has time, data and a flat structure behind it. Four audits a year, a clinician who reads the trend, a messaging channel that answers against your history and a pharmacy transaction we take nothing from. If your current primary care already delivers all of that, keep them and skip us and we mean that sincerely. If your last three visits produced a glucose-only screen and a pamphlet, the membership is the difference and the eligibility check costs nothing to find out which one you have.

Who this is not for

If you want a prescription without labs, the Biomarker Audit comes first and we will not skip it. If you want compounded vials, we do not prescribe them and we will not pretend otherwise. And if you are outside the United States, our clinicians are licensed in the fifty states and cannot serve you.

One last thing

The most useful question is not why won't my weight move. It is who will measure the six reasons and act on what they find. The eligibility check is free, takes a few minutes and never results in a charge unless a clinician accepts you into care.

Related Guides

References

  1. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP-1). NEJM. 2021. doi.org/10.1056/NEJMoa2032183
  2. American Thyroid Association, hypothyroidism. thyroid.org